Registration

DB3, LLC (FKA THE DASCHLE GROUP) for REASON FOR HOPE

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Breakthrough Therapies Act (H.R.1393/S.689), psychedelics research and treatment policy, in general.

LobbyistCovered position, as disclosed
THOMAS DASCHLE New Former United States Senator
CHARLES D PANFIL New —

Bills named: H.R. 1393 (118th), S. 689 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.